Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

NCX-2111: a new NicOx NO-releasing compound for micturition disorders

Sep. 26, 2001

Phase II trial data support efficacy of duloxetine in stress urinary incontinence

Sep. 21, 2001

Muscarinic receptor binding profile of YM-905 correlated with pharmacological activity

Sep. 20, 2001

Tiagabine as a potential treatment option for overactive bladder

Sep. 20, 2001

Human testing of injectable urethral bulking agent in progress

Sep. 20, 2001

Men with diabetes-related ED respond well to on-demand treatment with IC-351

Sep. 17, 2001

Interneuron initiates U.S. phase III clinical trial with trospium for overactive bladder

Sep. 13, 2001

Topiglan development continues to move forward

Sep. 12, 2001

BTG obtains rights to ANF peptide technology from Genentech

Sep. 10, 2001

Z-350 may reduce prostate growth without other hormonal effects

Sep. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...